UroGen Pharma
URGN
URGN
85 hedge funds and large institutions have $137M invested in UroGen Pharma in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
36% less call options, than puts
Call options by funds: $193K | Put options by funds: $300K
Holders
85
Holding in Top 10
–
Calls
$193K
Puts
$300K
Top Buyers
| 1 | +$8.42M | |
| 2 | +$3.09M | |
| 3 | +$1.94M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.63M |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$1.58M |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$2.62M | |
| 3 | -$1.93M | |
| 4 |
Millennium Management
New York
|
-$1.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.03M |